Nov 05, 2020 4:30pm EST iBio to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Update on Monday, November 16 ,2020
Oct 15, 2020 4:05pm EDT Accomplished Financial Executive, Gary Sender, Joins iBio’s Board of Directors
Oct 02, 2020 7:00am EDT iBio Enters into Agreement with Safi Biosolutions to Develop Growth Factors and Cytokines Using the FastPharming® System
Aug 28, 2020 7:15am EDT iBio and Planet Biotechnology Enter into Exclusive Worldwide License Agreement for the Development of a COVID-19 Therapeutic
